Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Automotive Regulatory News (CTA)

Share Price Information for Ct Automotive (CTA)

Share Price is delayed by 15 minutes
Get Live Data
32.50    0.00 (0.00%)
Bid:
32.00
Ask:
33.00
Spread: 1.00 (3.125%)
Market Cap: £23.92m
CTA Live PriceLast checked at - London Stock Exchange

Intraday Ct Automotive Share Chart

Director Appointment

16 Feb 2026 07:00

RNS Number : 0406T
CT Automotive Group PLC
16 February 2026
Β 

16 February 2026

Β 

CT Automotive Group PLC

("CT Automotive" or the "Group")

Β 

Director Appointment

Β 

CT Automotive, a leading designer, developer and supplier of interior components to the global automotive industry, is pleased to announce the appointment of Gary McGrath as an Independent Non-Executive Director, effective immediately.

Gary McGrath is a Chartered Accountant with over 30 years' international finance experience across both listed and private multinational businesses. He has held senior finance leadership roles spanning strategic planning, operational finance, treasury, investor relations and corporate transactions. Most recently, Gary served for ten years as Group Chief Financial Officer of Zotefoams plc, a FTSE-listed world leader in supercritical foams, where he was responsible for the Group's global finance and IT functions and worked closely with the Chief Executive Officer on strategy, capital allocation and shareholder engagement.

Earlier in his career, Gary held a number of senior finance positions within international industrial and manufacturing businesses, working and living in Germany, Belgium and the USA, and gaining broad experience in commercial finance, operational restructuring and business transformation. He brings deep expertise in financial governance, capital markets and supporting growth in international organisations.

Raymond Bench, Chairman of CT Automotive, said:

"I am delighted to welcome Gary McGrath to the Board as an Independent Non-Executive Director. Gary's significant operational and listed company experience will be of great value to the Board, strengthening our strategic planning, governance, and investor relationships."

Regulatory Disclosures

Β 

Save for the information set out below, there are no further disclosures to be made in accordance with Rule 17, Schedule Two (g) of the AIM Rules for Companies in respect of the appointment of Gary Christopher McGrath, aged 58.

Β 

Current directorships and partnerships

Past directorships and partnerships (last 5 years)

No current directorships

Zotefoams plc

Zotefoams U.K. Limited

Zotefoams International Ltd

Zotefoams Technology Limited

Zotefoams Inc.

Zotefoams Midwest LLC.

MuCell Extrusion LLC.

Zotefoams Poland Sp.z.o.o.

T-FIT Insulation Solutions India Private Ltd

Β 

Gary Christopher McGrath does not hold any interest in the ordinary shares of the Company.Β 

Β 

Enquiries:

CT Automotive

Raymond Bench, Non-Executive Chairman

Simon Phillips, Chief Executive Officer

Β 

Β 

Singer Capital Markets Advisory LLP (Nominated Adviser and Broker)

Alex Bond, James Todd, Samed Ethemi

Β 

Β 

Tel: +44 (0)20 7496 3000

Β 

Β 

Notes to editors

CT Automotive is engaged in the design, development and manufacture of bespoke automotive interior finishes (for example, dashboard panels and fascia finishes) and kinematic assemblies (for example, air registers, arm rests, deployable cup holders and storage systems), as well as their associated tooling, for the world's leading automotive original equipment manufacturers ("OEMs") and global Tier One manufacturers.

Β 

The Group is headquartered in the UK with a low cost manufacturing footprint. Key production facilities are located in Shenzhen and Ganzhou, China with additional manufacturing facilities in Mexico and TΓΌrkiye and distribution facilities and assembly lines in Europe, Asia and the US. The Company has a low cost design and administrative centre in India.

CT Automotive's operating model enables it to pursue a price leadership strategy, supplying high quality parts to customers at a lower overall landed cost than competitors. This has helped the Group build a high-quality portfolio of OEM customers, both directly and via Tier One suppliers including Forvia and Marelli. End customers include volume manufacturers, such as Nissan, Ford, GM and Volkswagen Audi Group, and premium luxury car brands such as Bentley and Lamborghini. In addition, the Group supplies all our customer base with a range of products for PHEV and BEV platforms and supplies electric car manufacturers, including Rivian and a US based major EV OEM.

The Group currently supplies component part types to over 55 different models for 22 OEMs. Since its formation, the Group has been one of the very few new entrants to the market, which is characterised by high barriers to entry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAEAAALFLKKEFA
Date   Source Headline
22nd May 20247:30 amRNSDirector/PDMR Shareholding
20th May 20247:00 amRNSInvestor Presentation
20th May 20247:00 amRNSFinal Results
2nd Feb 20247:00 amRNSGrant of awards under Long Term Incentive Plan
26th Jan 20247:00 amRNSFull Year Trading Update
27th Dec 20234:30 pmRNSDirector/PDMR Dealing
21st Dec 20231:00 pmRNSGrant of awards under Long Term Incentive Plan
8th Nov 20233:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSDirector Appointment
17th Aug 20239:56 amRNSDirectorate Change
13th Jul 20234:30 pmRNSBoard Changes
13th Jul 20233:56 pmRNSResult of Annual General Meeting
20th Jun 20235:10 pmRNSNotice of AGM
19th Jun 20237:00 amRNSDirectorate Change
16th Jun 20237:00 amRNSResults for the year ended 31 December 2022
18th May 20233:33 pmRNSHolding(s) in Company
18th May 20231:31 pmRNSHolding(s) in Company
15th May 20234:16 pmRNSResult of General Meeting and Total Voting Rights
12th May 20237:00 amRNSInventory balance sheet adjustments
4th May 20237:00 amRNSUpdate on FY22 preliminary results
28th Apr 202310:13 amRNSDirectorate Change - CFO
27th Apr 20233:15 pmRNSResult of Fundraising
27th Apr 20237:30 amRNSFundraising of approximately £7.6 million
1st Feb 20237:00 amRNSChief Financial Officer appointment
13th Dec 20227:00 amRNSBoard Change
8th Dec 20224:05 pmRNSTrading Update
23rd Sep 202211:56 amRNSGrant of awards under Long Term Incentive Plan
20th Sep 20227:00 amRNSH1 2022 Results
22nd Aug 20222:45 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSTrading Update
5th Jul 202212:38 pmRNSResult of AGM
30th Jun 20227:00 amRNSGrant of awards under Long Term Incentive Plan
6th Jun 20224:00 pmRNSAnnual Report and Accounts 2021 and 2022 AGM
19th May 20227:00 amRNSResults for the year ended 31 December 2021
16th May 202212:55 pmRNSNotice of Results
14th Feb 20227:00 amRNSTrading Update
30th Dec 20214:34 pmRNSHolding(s) in Company
30th Dec 20214:32 pmRNSHolding(s) in Company
30th Dec 20214:30 pmRNSHolding(s) in Company
30th Dec 20214:25 pmRNSHolding(s) in Company
23rd Dec 20217:00 amRNSAdmission to trading on AIM
12th Dec 20137:00 amRNSForm 8-K
12th Dec 20137:00 amRNSCaterpillar Files S-8 registration statement
11th Dec 20133:59 pmRNSDividend Declaration
5th Dec 20137:00 amRNSDirector/PDMR Shareholding
4th Dec 20137:00 amRNSDirector/PDMR Shareholding
3rd Dec 20137:00 amRNSDirector/PDMR Shareholding
2nd Dec 20135:11 pmRNSIntention to Cancel Listing
18th Nov 20135:54 pmRNSIntention to Cancel Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.